Aktis Oncology, Inc. (AKTS): 6 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jan 14, 2026 | Gadicke Ansbert TenPercentOwner | 1,112,777 | $18.00 | $20.0M | no history |
| Jan 14, 2026 | Mpm Oncology Innovations Fund Lp TenPercentOwner | 1,112,777 | $18.00 | $20.0M | no history |
| Jan 14, 2026 | Foley Todd Director, TenPercentOwner | 232,870 | $18.00 | $4.2M | no history |
| Jan 12, 2026 | Kim Helen Susan Director, TenPercentOwner | 835,000 | $18.00 | $15.0M | no history |
| Jan 12, 2026 | Vida Ventures Ii-A, Llc TenPercentOwner | 835,000 | $18.00 | $15.0M | no history |
| Jan 12, 2026 | Nodelman Oleg Director | 2,222,222 | $18.00 | $40.0M | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.